Related Experiment Video
Updated: Sep 19, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
Respiratory Manifestations in Pediatric Patients With Interleukin 6 Receptor Deficiency
Noga Arwas1,2, Eyal Kristal2,3, Inbal Golan-Tripto1,2
1Pediatric Pulmonology Unit, Soroka University Medical Center, Beer Sheva, Israel.
Pediatric Pulmonology
|June 19, 2025
Summary
Interleukin-6 receptor (IL-6R) deficiency presents with varied respiratory issues in children but typically avoids early bronchiectasis. Routine imaging is recommended for monitoring lung complications due to atypical inflammatory markers.
Area of Science:
- Immunology
- Pediatrics
- Respiratory Medicine
Background:
- Interleukin-6 receptor (IL-6R) deficiency is a rare primary immunodeficiency.
- It impairs interleukin-6 (IL-6) signaling, impacting immune responses and respiratory health.
- Pediatric patients exhibit a range of respiratory symptoms, from mild to severe infections.
Discussion:
- Despite respiratory infections, early bronchiectasis is not a common feature in pediatric IL-6R deficiency.
- Absence of typical inflammatory markers in lung infections complicates diagnosis and monitoring.
- Routine imaging is crucial for detecting potential pulmonary complications.
Key Insights:
- IL-6R deficiency leads to diverse respiratory presentations in children.
- Atypical inflammatory profiles necessitate vigilant monitoring for lung issues.
- Early detection of complications via imaging is vital for patient management.
Outlook:
- Further research into IL-6R's role in pediatric respiratory health is warranted.
- Developing novel diagnostic markers for lung infections in immunodeficient patients is essential.
- Long-term follow-up studies will clarify the natural history and management strategies for IL-6R deficiency.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
1.8K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K
01:23Acute Respiratory Failure-IV
241
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
241
01:17Other Pulmonary Disorders
914
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
914
01:21Acute Respiratory Failure-II
384
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
384
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K